CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
暂无分享，去创建一个
D. Sahoo | M. van de Rijn | S. Paik | N. Wolmark | M. Clarke | T. Kalisky | P. Dalerba | G. Yothers | Erna Forgó | D. Qian | N. Song | Xiangqian Guo | G. Fisher | S. Hisamori | Pradeep S. Rajendran | S. Miranda | J. Hutchison | Nate Wilcox-Fogel